Rosacea Sensitive Skin
AI recommendation signal analysis across 345 domains for the Rosacea Sensitive Skin persona in Dermatology Groups.
Many tables and charts on this page show only the top few results; the full data behind them runs far deeper. The complete report unlocks every row, chart, and download for this industry.
Get the full Dermatology Groups report →How to use this page
Pitch the trades
The trade journals covering this industry. Target them for PR, contributed articles, and industry announcements.
Where the numbers come from
We run trade journals queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.
What's on this page
Domain and URL charts, the full result list, and title n-gram tables.
Research: Trade Journals
Domains appearing in Google results for Rosacea Sensitive Skin's Research: Trade Journals queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.
Top URLs
Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.
All Results
Every result for Rosacea Sensitive Skin's Research: Trade Journals queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.
Title N-Grams
Most common word phrases (2 to 7 words) across every result title for these queries.
2-grams
| 17 | rosacea treatment |
| 13 | for rosacea |
| 11 | in rosacea |
| 7 | of rosacea |
| 7 | fda approves |
| 6 | journey medical |
| 4 | advances in |
| 4 | in the |
| 4 | and treatment |
| 4 | rosacea in |
| 4 | of the |
| 4 | trial results |
| 4 | reports positive |
| 3 | treatment of |
| 3 | new concepts |
| 3 | concepts in |
| 3 | classification and |
| 3 | treatment emrosi |
| 3 | treatment options |
| 3 | treatment and |
| 3 | phase 3 |
| 3 | rosacea management |
| 3 | medical s |
| 3 | results for |
| 2 | the latest |
3-grams
| 3 | new concepts in |
| 3 | classification and treatment |
| 3 | rosacea treatment emrosi |
| 3 | journey medical s |
| 2 | advances in the |
| 2 | in the treatment |
| 2 | the treatment of |
| 2 | treatment of rosacea |
| 2 | novel rosacea treatment |
| 2 | fda approves rosacea |
| 2 | approves rosacea treatment |
| 2 | rosacea treatment options |
| 2 | treatment options for |
| 2 | rosacea treatment market |
| 2 | treatment market size |
| 2 | isotretinoin for rosacea |
| 2 | dermatology of the |
| 2 | of the phase |
| 2 | the phase 3 |
| 2 | phase 3 clinical |
| 2 | 3 clinical trial |
| 2 | clinical trial results |
| 2 | trial results of |
| 2 | results of emrosi |
| 2 | rosacea management a |
4-grams
| 2 | in the treatment of |
| 2 | fda approves rosacea treatment |
| 2 | approves rosacea treatment emrosi |
| 2 | rosacea treatment market size |
| 2 | dermatology of the phase |
| 2 | of the phase 3 |
| 2 | the phase 3 clinical |
| 2 | phase 3 clinical trial |
| 2 | 3 clinical trial results |
| 2 | clinical trial results of |
| 2 | trial results of emrosi |
| 2 | journey medical s emrosi |
| 2 | journey medical reports positive |
| 2 | medical reports positive phase |
| 2 | reports positive phase 1 |
| 2 | positive phase 1 results |
| 2 | phase 1 results for |
| 2 | new concepts in rosacea |
| 2 | concepts in rosacea classification |
| 2 | in rosacea classification and |
| 2 | rosacea classification and treatment |
| 2 | fda approves emrosi for |
| 2 | approves emrosi for rosacea |
| 2 | emrosi for rosacea in |
| 2 | for rosacea in adults |
5-grams
| 2 | fda approves rosacea treatment emrosi |
| 2 | dermatology of the phase 3 |
| 2 | of the phase 3 clinical |
| 2 | the phase 3 clinical trial |
| 2 | phase 3 clinical trial results |
| 2 | 3 clinical trial results of |
| 2 | clinical trial results of emrosi |
| 2 | journey medical reports positive phase |
| 2 | medical reports positive phase 1 |
| 2 | reports positive phase 1 results |
| 2 | positive phase 1 results for |
| 2 | new concepts in rosacea classification |
| 2 | concepts in rosacea classification and |
| 2 | in rosacea classification and treatment |
| 2 | fda approves emrosi for rosacea |
| 2 | approves emrosi for rosacea in |
| 2 | emrosi for rosacea in adults |
| 1 | the latest in rosacea news |
| 1 | current trends and future insights |
| 1 | trends and future insights on |
| 1 | and future insights on rosacea |
| 1 | future insights on rosacea treatment |
| 1 | advances in the treatment of |
| 1 | in the treatment of rosacea |
| 1 | the treatment of rosacea associated |
6-grams
| 2 | dermatology of the phase 3 clinical |
| 2 | of the phase 3 clinical trial |
| 2 | the phase 3 clinical trial results |
| 2 | phase 3 clinical trial results of |
| 2 | 3 clinical trial results of emrosi |
| 2 | journey medical reports positive phase 1 |
| 2 | medical reports positive phase 1 results |
| 2 | reports positive phase 1 results for |
| 2 | new concepts in rosacea classification and |
| 2 | concepts in rosacea classification and treatment |
| 2 | fda approves emrosi for rosacea in |
| 2 | approves emrosi for rosacea in adults |
| 1 | current trends and future insights on |
| 1 | trends and future insights on rosacea |
| 1 | and future insights on rosacea treatment |
| 1 | advances in the treatment of rosacea |
| 1 | in the treatment of rosacea associated |
| 1 | the treatment of rosacea associated facial |
| 1 | rosacea roundup the year so far |
| 1 | rosacea new concepts in classification and |
| 1 | new concepts in classification and treatment |
| 1 | a 68 year old woman with |
| 1 | 68 year old woman with rosacea |
| 1 | year old woman with rosacea presented |
| 1 | old woman with rosacea presented to |
7-grams
| 2 | dermatology of the phase 3 clinical trial |
| 2 | of the phase 3 clinical trial results |
| 2 | the phase 3 clinical trial results of |
| 2 | phase 3 clinical trial results of emrosi |
| 2 | journey medical reports positive phase 1 results |
| 2 | medical reports positive phase 1 results for |
| 2 | new concepts in rosacea classification and treatment |
| 2 | fda approves emrosi for rosacea in adults |
| 1 | current trends and future insights on rosacea |
| 1 | trends and future insights on rosacea treatment |
| 1 | advances in the treatment of rosacea associated |
| 1 | in the treatment of rosacea associated facial |
| 1 | rosacea new concepts in classification and treatment |
| 1 | a 68 year old woman with rosacea |
| 1 | 68 year old woman with rosacea presented |
| 1 | year old woman with rosacea presented to |
| 1 | old woman with rosacea presented to clinic |
| 1 | woman with rosacea presented to clinic with |
| 1 | with rosacea presented to clinic with a |
| 1 | rosacea presented to clinic with a 6 |
| 1 | efficacy of a novel rosacea treatment system |
| 1 | rosacea treatment update recommendations from the global |
| 1 | 2025 s review of rosacea treatment options |
| 1 | s review of rosacea treatment options cost |
| 1 | review of rosacea treatment options cost vs |